Back to Agenda
Session 7: FUTURE OF PV (People, Process, Technology and Partnerships)
Session Chair(s)
Gurpreet Singh
Chief Business Officer, Pharmacovigilance & Clinical, Pivot Path, United Kingdom
Session Overview: The future of pharmacovigilance (PV) is defined by a shift toward smarter, more proactive, and more connected drug safety systems. By 2030, PV is expected to rely heavily on real time data, AI driven analytics, and closer engagement with patients and clinicians. Regulators anticipate major changes in how safety information is collected and used, including more efficient reporting of suspected adverse reactions and continuous monitoring of medicines’ real world performance.
Speaker(s)
The Next Frontier of Patient Safety - Harnessing Semantics, Graph RAG & Agentic AI for Intelligent Safety Insights
Prachet Mohanty
Associate Director, Research & Development BI&T (WWPS & GRS), Bristol Myers Squibb, India
Panel Discussion with Q&A: Future of PV- The need for Patient Centric PV amidst evolving Regulations and Technology Transformations
J Vijay Venkatraman
Managing Director and CEO, Oviya Medsafe Pvt Ltd, India
Inder Sachdeva
Vice President, Safety and PV, Syneos Health, India
Prachi Arora, MD
Vice President and Head Medical Safety, APCER Life Sciences, United States
Rohini Pandey
Associate Director – Regional PV SEA, Abbott, India
Anuja Sawant
Associate Director, Area Safety Head, kenvue, India
From Silos to Seamless: The Integrated Future of PV Process and Technology
Sanjeev Srivastav
Signal Management Lead, BioNTech, India
Have an account?